These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3141351)

  • 1. In-vitro activity of ofloxacin against isolates of Neisseria gonorrhoeae.
    McEwen A; Roberts G
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():21-5. PubMed ID: 3141351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeae.
    Fuchs PC; Barry AL; Baker C; Murray PR; Washington JA
    J Clin Microbiol; 1992 Apr; 30(4):1024-6. PubMed ID: 1572960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro activity of norfloxacin, ofloxacin and ciprofloxacin and other antibiotics in current use against Neisseria gonorrhoeae.
    Melby K; Faegri A
    APMIS; 1989 Apr; 97(4):347-50. PubMed ID: 2497756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan.
    Tanaka M; Kumazawa J; Matsumoto T; Kobayashi I
    Genitourin Med; 1994 Apr; 70(2):90-3. PubMed ID: 8206482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid decline in penicillinase-producing Neisseria gonorrhoeae in Hong Kong associated with emerging 4-fluoroquinolone resistance.
    Kam KM; Lo KK; Ho NK; Cheung MM
    Genitourin Med; 1995 Jun; 71(3):141-4. PubMed ID: 7635487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of ofloxacin against Neisseria gonorrhoeae].
    Korting HC; Lukacs A
    Immun Infekt; 1988 Feb; 16(1):3-5. PubMed ID: 3129357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 May; 43(18):325-7. PubMed ID: 8164636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ofloxacin susceptibilities of 5,667 Neisseria gonorrhoeae strains isolated in Hong Kong.
    Kam KM; Lo KK; Lai CF; Lee YS; Chan CB
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2007-8. PubMed ID: 8239622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of Neisseria gonorrheae strains in three regions of Armenia.
    Hovhannisyan G; von Schoen-Angerer T; Babayan K; Fenichiu O; Gaboulaud V
    Sex Transm Dis; 2007 Sep; 34(9):686-8. PubMed ID: 17621247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of quinolone-resistant Neisseria gonorrhoeae in Pakistan.
    Jabeen K; Khan E; Hasan R
    Int J STD AIDS; 2006 Jan; 17(1):30-3. PubMed ID: 16409676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of seven quinolone derivatives against Neisseria gonorrhoeae.
    van der Willigen AH; Degener JE; Vogel M; Stolz E; Wagenvoort JH
    Arzneimittelforschung; 1990 Jun; 40(6):684-5. PubMed ID: 2118763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of six quinolone derivatives against Neisseria gonorrhoeae.
    Lefèvre JC; Tempesta MC; Gaubert E; Lareng MB
    Chemotherapy; 1988; 34(4):315-7. PubMed ID: 2850138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of the Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates Collected in Changsha, China from 2003 to 2015.
    Peng T; Lin H; Liu Q; Yang J; Cao W; Ding H; Tang L
    Jpn J Infect Dis; 2017 Sep; 70(5):518-521. PubMed ID: 28367885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the Centers for Disease Control and Prevention. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
    JAMA; 1994 Jun; 271(22):1733-4. PubMed ID: 8196105
    [No Abstract]   [Full Text] [Related]  

  • 15. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.
    Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E
    East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of norfloxacin and ofloxacin for treatment of gonorrhoea and decrease of in vitro susceptibility to quinolones over time in Rwanda.
    Bogaerts J; Tello WM; Akingeneye J; Mukantabana V; Van Dyck E; Piot P
    Genitourin Med; 1993 Jun; 69(3):196-200. PubMed ID: 8335312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rising quinolone resistance in Neisseria gonorrhoeae isolates from New Delhi.
    Bhalla P; Vidhani S; Reddy BS; Chowdhry S; Mathur MD
    Indian J Med Res; 2002 Mar; 115():113-7. PubMed ID: 12201175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the gyrA and parC genes of quinolone-resistant Neisseria gonorrhoeae isolates in India.
    Kulkarni S; Bala M; Sane S; Pandey S; Bhattacharya J; Risbud A
    Int J Antimicrob Agents; 2012 Dec; 40(6):549-53. PubMed ID: 23063097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility testing of Neisseria gonorrhoeae isolates in Pakistan by Etest compared to Calibrated Dichotomous Sensitivity and Clinical Laboratory Standards Institute disc diffusion techniques.
    Mal PB; Jabeen K; Farooqi J; Unemo M; Khan E
    BMC Microbiol; 2016 Oct; 16(1):236. PubMed ID: 27724873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.